CIBC Asset Management Inc Has $3.83 Million Stock Holdings in The Cooper Companies, Inc. $COO

CIBC Asset Management Inc lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 69.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 46,763 shares of the medical device company’s stock after buying an additional 19,154 shares during the quarter. CIBC Asset Management Inc’s holdings in Cooper Companies were worth $3,833,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the company. Goldman Sachs Group Inc. lifted its stake in Cooper Companies by 56.3% in the 4th quarter. Goldman Sachs Group Inc. now owns 794,963 shares of the medical device company’s stock valued at $65,155,000 after acquiring an additional 286,362 shares in the last quarter. Natixis Advisors LLC lifted its stake in Cooper Companies by 820.1% in the 4th quarter. Natixis Advisors LLC now owns 303,456 shares of the medical device company’s stock valued at $24,871,000 after acquiring an additional 270,476 shares in the last quarter. Root Financial Partners LLC lifted its stake in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares in the last quarter. BNP Paribas bought a new stake in Cooper Companies in the 4th quarter valued at approximately $61,000. Finally, MKP Capital Management L.L.C. bought a new stake in Cooper Companies in the 4th quarter valued at approximately $16,392,000. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Stifel Nicolaus cut their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday. Needham & Company LLC dropped their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday. Finally, JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Cooper Companies currently has an average rating of “Hold” and an average price target of $82.64.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $67.34 on Monday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The stock has a market cap of $13.14 billion, a P/E ratio of 57.07, a P/E/G ratio of 1.73 and a beta of 0.88. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The business’s 50 day moving average is $65.09 and its 200-day moving average is $74.54.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the business posted $0.96 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper Companies posted better-than-expected Q2 results, with EPS of $1.21 topping estimates of $1.10 and revenue of $1.08 billion beating forecasts, while sales rose 7.9% year over year. CooperCompanies Announces Second Quarter 2026 Results
• Positive Sentiment: Management said it reached agreements to resolve substantially all claims tied to the prior fertility media recall, reducing a major legal overhang and supporting investor confidence in the company’s outlook. QuiverQuant article
• Positive Sentiment: Needham reaffirmed a Buy rating on COO and lowered its price target to $86, still implying meaningful upside from current levels. TipRanks analyst update
• Positive Sentiment: Stifel, Baird, and JPMorgan all cut price targets but kept constructive ratings, suggesting analysts see the report as solid even after valuation resets. Benzinga analyst update
• Neutral Sentiment: The company guided FY2026 EPS to $4.58-$4.66, slightly around consensus, which helps confirm expectations but does not point to a major near-term surprise. Earnings report transcript
• Negative Sentiment: JPMorgan lowered its price target on COO from $80 to $71 and kept a Neutral rating, reflecting more cautious expectations despite the stock’s recent strength. JPMorgan price target update

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.